Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)

Clinical trial NCT02484716 · COMPLETED

Trial details

NCT number: NCT02484716
Sponsor: Hospices Civils de Lyon
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Telangiectasia, Hereditary Hemorrhagic Osler Rendu Disease

Start date: 2015-06-01
Primary completion: 2017-11-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.